Holen Sie sich die Stockscreener-App
0.6124
2.79%
-0.0176
Schlusskurs vom Vortag:
$0.63
Offen:
$0.6618
24-Stunden-Volumen:
5,425
Relative Volume:
0.12
Marktkapitalisierung:
$3.32M
Einnahmen:
$4.14M
Nettoeinkommen (Verlust:
$-3.19M
KGV:
-0.8197
EPS:
-0.7471
Netto-Cashflow:
$11,000
1W Leistung:
-0.07%
1M Leistung:
+9.03%
6M Leistung:
-67.32%
1J Leistung:
-72.41%
1-Tages-Spanne:
$0.6101
$0.6619
1-Wochen-Bereich:
$0.55
$0.6775
52-Wochen-Spanne:
$0.5003
$2.5977
China Pharma Holdings Inc. Stock (CPHI) Company Profile
Firmenname
China Pharma Holdings Inc.
Sektor
Telefon
86 898 6681 1730
Adresse
No. 17, Jinpan Road, Second Floor, Haikou
Compare CPHI vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CPHI
China Pharma Holdings Inc.
|
0.6619 | 3.16M | 4.14M | -3.19M | 11,000 | -0.7471 |
TAK
Takeda Pharmaceutical Co Adr
|
18.21 | 59.20B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
118.20 | 49.79B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.925 | 44.27B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.67 | 35.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
555.45 | 24.75B | 3.18B | 1.33B | 1.04B | 27.90 |
China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2010-01-08 | Eingeleitet | Rodman & Renshaw | Mkt Outperform |
China Pharma Holdings Inc. Aktie (CPHI) Neueste Nachrichten
China Pharma (NYSE:CPHI) & Acerus Pharmaceuticals (OTCMKTS:ASPCF) Financial Comparison - Defense World
CUPR PE Ratio & Valuation, Is CUPR Overvalued - Intellectia AI
DRMA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Stock List: Research Stocks from Around the World - GuruFocus
China Pharma Holdings, Inc. (XQJ.DE) Analyst insights, Price targets and Recommendations - Yahoo Finance Singapore
China Pharma Holdings, Inc. (XQJ.DE) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
China Pharma Delays 10-K but Shows Narrowing Losses - The Globe and Mail
China Pharma Holdings 2026 Annual Report: Strategic Focus on Generic Drugs, Market Expansion, and Innovation in China’s Pharmaceutical Industry - Minichart
China Pharma Holdings Files For Non-Timely 10-K With US SEC - TradingView
China Pharma Holdings 10-K: Revenue $4.14M, Loss per Share $(0.74) - TradingView
China Pharma (NYSE American: CPHI) details 2025 losses and China policy risks - Stock Titan
China Pharma Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Buy Signal: Can China Pharma Holdings Inc keep up with sector leadersBull Run & Trade Opportunity Analysis - baoquankhu1.vn
USA Stocks: Research Stocks from USA Stock Market - GuruFocus
Risk Report: How does China Pharma Holdings Inc perform in inflationary periods2026 Growth vs Value & Capital Protection Trade Alerts - baoquankhu1.vn
China NT Pharma Group Announces Reduced Net Loss for 2025 After One-Off Non-Cash Gain – Profit Warning Update - Minichart
Market Outlook: How does China Pharma Holdings Inc perform in inflationary periodsForecast Cut & AI Forecasted Entry/Exit Points - baoquankhu1.vn
Aug Technicals: Can China Pharma Holdings Inc expand into new marketsQuarterly Investment Review & Stepwise Trade Signal Implementation - baoquankhu1.vn
Jobs Data: Is China Pharma Holdings Incs ROE strong enough2026 Year in Review & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Aug Drivers: Can China Pharma Holdings Inc keep up with sector leadersTrade Analysis Report & Low Volatility Stock Recommendations - baoquankhu1.vn
If You Invested $1,000 in China Pharma (CPHI) - Stock Titan
Quarterly Trades: How does China Pharma Holdings Inc perform in inflationary periodsMarket Sentiment Report & AI Enhanced Execution Alerts - baoquankhu1.vn
MGRX Financials: Revenue Breakdown, Margins & Competitor Comparison - intellectia.ai
China Medical System Holdings SEHK 867 Margin Decline Tests Bullish Growth Narrative - simplywall.st
Market Outlook: Will China Pharma Holdings Inc be affected by tariffs2026 Key Lessons & Safe Swing Trade Setups - baoquankhu1.vn
Assessing China Medical System (SEHK:867) Valuation After A Recent Share Price Pullback - simplywall.st
Investment Recap: How correlated is NCDL to the S P500Long Setup & Weekly Momentum Stock Picks - baoquankhu1.vn
Bearish Setup: How does China Pharma Holdings Inc perform in inflationary periods2026 Winners & Losers & Low Drawdown Investment Strategies - baoquankhu1.vn
Volume Recap: What are the analyst revisions for Amdocs LimitedIs CTEV stock a good investment in YEARProduct Launch & AI Based Buy and Sell Signals - baoquankhu1.vn
Can China Pharma Holdings Inc lead its sector in growth2026 Momentum Check & Target Return Focused Picks - baoquankhu1.vn
Will Pony AI Inc. Depositary Receipt stock continue dividend increases2026 Support & Resistance & Reliable Intraday Trade Plans - Naître et grandir
How GreenTree Hospitality Group Ltd. American stock performs during market turbulencePortfolio Risk Report & Weekly Return Optimization Plans - Naître et grandir
Volume Report: Is Central Plains Bancshares Inc backed by strong institutional buyingRisk Management & Community Consensus Trade Alerts - baoquankhu1.vn
Is Southland Holdings Inc. Equity Warrant stock a dividend growth opportunityIPO Watch & Risk Controlled Daily Trade Plans - Naître et grandir
Fed Watch: Is China Pharma Holdings Incs ROE strong enoughJuly 2025 Trade Ideas & Stepwise Trade Execution Plans - baoquankhu1.vn
Trade Recap: Can China Pharma Holdings Inc expand into new marketsJuly 2025 Intraday Action & Community Consensus Trade Signals - baoquankhu1.vn
Form 10-KAnnual Reports - Stock Titan
China Pharma Expands R&D Portfolio With Patent Acquisition - TipRanks
Quarterly Risk: Can China Pharma Holdings Inc keep up with sector leadersJuly 2025 WrapUp & Fast Gain Stock Trading Tips - baoquankhu1.vn
getLinesFromResByArray error: size == 0 - mfd.ru
Naproxen Patches Market Growth Fueled by Shift from Oral Nsaids, Forecast to 2035News and Statistics - IndexBox
CPHI Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
GLMD PE Ratio & Valuation, Is GLMD Overvalued - Intellectia AI
Inflation Data: Is Blackstone Inc affected by consumer sentimentQuarterly Earnings Summary & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Risk Check: Is China Pharma Holdings Inc part of any ETFQuarterly Growth Report & Smart Investment Allocation Insights - baoquankhu1.vn
Risk Analysis: Can NESRW lead its sector in growthShare Buyback & Trade Opportunity Analysis - baoquankhu1.vn
BIT Capital GmbH Reduces Holdings in BridgeBio Pharma, Inc. $BBIO - Defense World
CPHI Should I Buy - Intellectia AI
Winners Losers: Is GoldMining Inc part of any ETFMarket Sentiment Summary & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
The China factor: US pharma group campaigns for increased competitiveness - Yahoo Finance
PAPLD Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Finanzdaten der China Pharma Holdings Inc.-Aktie (CPHI)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):